Frank Rimerman Advisors’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Frank Rimerman Advisors’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,556	Closed	-$18.3K	–	318
2023 Q3	$18.3K	Hold	5,556	–	–	﹤0.01%	101
2023 Q2	$28.5K	Hold	5,556	–	–	0.01%	112
2023 Q1	$24.4K	Hold	5,556	–	–	0.01%	108
2022 Q4	$24.8K	Hold	5,556	–	–	0.01%	96
2022 Q3	$88.4K	Hold	5,556	–	–	0.03%	93
2022 Q2	$261K	Buy	+5,556	New	+$322K	0.1%	72

Frank Rimerman Advisors's UTRS Position: Q4 2023 in Review

Frank Rimerman Advisors sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 5,556 shares — an estimated $18.3K sold.

Frank Rimerman Advisors first reported a position in UTRS in Q2 2022 and held it in 6 quarters. The position peaked at $261K in Q2 2022. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

Frank Rimerman Advisors reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Frank Rimerman Advisors sold 5,556 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $18.3K.
Frank Rimerman Advisors first reported a position in Minerva Surgical, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Frank Rimerman Advisors's Minerva Surgical, Inc. Common Stock position peaked at $261K in Q2 2022.
0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Frank Rimerman Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.